Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Primary ciliary dyskinesia panel. 36-gene NGS panel. Genologica Medica Spain | 46 | 35 |
|
Heterotaxy and situs inversus panel. 32-gene NGS panel. Genologica Medica Spain | 34 | 31 |
|
Heterotaxy & Situs Inversus Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 7 | 36 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
PIH1D3 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Prenatal Known Familial Mutation GeneDx United States | 1 | 1716 |
|
Custom XomeDxSlice (2-150 Genes, Proband Only) GeneDx United States | 1 | 1718 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Primary Ciliary Dyskinesia NGS Panel Fulgent Genetics United States | 55 | 38 |
|
Fulgent Genetics United States | 1 | 1 |
|
Heterotaxy and Situs Inversus Panel Blueprint Genetics Finland | 2 | 32 |
|
Primary Ciliary Dyskinesia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 38 | 38 |
|
Comprehensive Pulmonary-Vascular Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 100 | 86 |
|
Primary Ciliary Dyskinesia Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 42 | 42 |
|
Comprehensive Pulmonology Panel Blueprint Genetics Finland | 5 | 66 |
|
Primary Ciliary Dyskinesia Panel Blueprint Genetics Finland | 3 | 36 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 156 | 114 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.